Websites targeting keyword biotechnology investor relations

MacDougall Biomedical Communications (MBI) is a team of experienced, multi-talented consultants spanning two locations – Boston and Munich – providing an integrated suite of media relations (pr), investor relations (ir), corporate communications and creative design services to life sciences companies of all sizes and stages, public and private. MBI offers its clients an unparalleled global network of contacts and expertise addressing all key audiences: investors, media, partners, and the medical and scientific communities at large. For more information, visit us at www.macbiocom.com.

HemoGenyx is a preclinical-stage biotechnology company focused on the discovery, development and commercialisation of novel therapies and treatments for blood diseases, like leukemia and lymphoma. The company's leading technologies aim to change the way in which bone marrow/hematopoietic stem cell (BM/HSC) transplants are performed and improve their efficacy.

LaVoieHealthScience provides strategic communications programs that integrate public and investor relations, marketing and communications to engage target